disease-free survival

• 

Potential biomarker to predict risk of recurrence after nephrectomy for locally advanced kidney cancer

By Robert|2021-07-07T11:13:05+00:0013 Apr 2021|Cancer news|

Currently, the search for a reliable biomarker to identify those [...]

Read More

Comments Off on Potential biomarker to predict risk of recurrence after nephrectomy for locally advanced kidney cancer

• 

Neutrophil-lymphocyte ratio as a prognostic biomarker in high-risk locally advanced kidney cancer

By Sharon Kell|2020-07-03T09:28:40+00:003 Jul 2020|Uncategorized|

An analysis of the data collected during the S-TRAC study, [...]

Read More

Comments Off on Neutrophil-lymphocyte ratio as a prognostic biomarker in high-risk locally advanced kidney cancer

• 

ESMO 2019: Results from SORCE clinical trial with adjuvant sorafenib

By Sharon Kell|2019-09-30T08:45:55+00:0030 Sep 2019|Drug treatments|

Results from the SORCE clinical trial to assess sorfenib as [...]

Read More

Comments Off on ESMO 2019: Results from SORCE clinical trial with adjuvant sorafenib

• 

CAR can be used to indicate survival in kidney cancer patients

By Sharon Kell|2019-05-08T08:12:47+00:008 May 2019|Cancer news|

A recent study with Japanese patients, published in Urologic Oncology [...]

Read More

Comments Off on CAR can be used to indicate survival in kidney cancer patients

• 

Adjuvant therapy for renal cell carcinoma

By Sharon Kell|2018-10-09T07:48:47+00:009 Oct 2018|Drug treatments|

The following articles from various urology conferences in 2018 summarise [...]

Read More

Comments Off on Adjuvant therapy for renal cell carcinoma

• 

Adjuvant sunitinib may increase symptoms and reduce quality of life in kidney cancer

By Sharon Kell|2018-09-10T07:43:39+00:0010 Sep 2018|Drug treatments|

A recent article in Annals of Oncology reports new patient-reported outcomes [...]

Read More

Comments Off on Adjuvant sunitinib may increase symptoms and reduce quality of life in kidney cancer